Literature DB >> 10403904

A receptor tyrosine kinase, UFO/Axl, and other genes isolated by a modified differential display PCR are overexpressed in metastatic prostatic carcinoma cell line DU145.

A N Jacob1, J Kalapurakal, W R Davidson, G Kandpal, N Dunson, Y Prashar, R P Kandpal.   

Abstract

We have used a modified differential display PCR protocol for isolating 3' restriction fragments of cDNAs specifically expressed or overexpressed in metastatic prostate carcinoma cell line DU145. Several cDNA fragments were identified that matched to milk fat globule protein, UFO/Axl, a receptor tyrosine kinase, human homologue of a Xenopus maternal transcript, laminin and laminin receptor, human carcinoma-associated antigen, and some expressed sequence tags. The transcript for milk fat globule protein, a marker protein shown to be overexpressed in breast tumors, was elevated in DU145 cells. The expression of UFO/Axl, a receptor tyrosine kinase, was considerably higher in DU145 cells as compared to normal prostate cells and prostatic carcinoma cell line PC-3. The overexpression of UFO oncogene in DU145 cells is discussed in the context of prostate cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403904     DOI: 10.1046/j.1525-1500.1999.99034.x

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  16 in total

1.  Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma.

Authors:  Xianzhou Song; Hua Wang; Craig D Logsdon; Asif Rashid; Jason B Fleming; James L Abbruzzese; Henry F Gomez; Douglas B Evans; Huamin Wang
Journal:  Cancer       Date:  2010-10-04       Impact factor: 6.860

2.  Cataract- and lens-specific upregulation of ARK receptor tyrosine kinase in Emory mouse cataract.

Authors:  Nancy L Sheets; Bharesh K Chauhan; Eric Wawrousek; J Fielding Hejtmancik; Ales Cvekl; Marc Kantorow
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-06       Impact factor: 4.799

3.  The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target.

Authors:  J D Paccez; G J Vasques; R G Correa; J F Vasconcellos; K Duncan; X Gu; M Bhasin; T A Libermann; L F Zerbini
Journal:  Oncogene       Date:  2012-03-12       Impact factor: 9.867

4.  Expression of axl in lung adenocarcinoma and correlation with tumor progression.

Authors:  Yi-Shing Shieh; Chiung-Ya Lai; Yu-Rung Kao; Shine-Gwo Shiah; Yi-Wen Chu; Herng-Sheng Lee; Cheng-Wen Wu
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

Review 5.  Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Expert Opin Ther Targets       Date:  2010-10       Impact factor: 6.902

6.  Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors.

Authors:  Sutapa Sinha; Justin Boysen; Michael Nelson; Charla Secreto; Steven L Warner; David J Bearss; Connie Lesnick; Tait D Shanafelt; Neil E Kay; Asish K Ghosh
Journal:  Clin Cancer Res       Date:  2015-02-11       Impact factor: 12.531

7.  GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche.

Authors:  Yusuke Shiozawa; Elisabeth A Pedersen; Lalit R Patel; Anne M Ziegler; Aaron M Havens; Younghun Jung; Jingcheng Wang; Stephanie Zalucha; Robert D Loberg; Kenneth J Pienta; Russell S Taichman
Journal:  Neoplasia       Date:  2010-02       Impact factor: 5.715

8.  Activated tyrosine kinases in gastrointestinal stromal tumor with loss of KIT oncoprotein expression.

Authors:  Yuqing Tu; Rui Zuo; Nan Ni; Grant Eilers; Duolin Wu; Yuting Pei; Zuoming Nie; Yeqing Wu; Yuehong Wu; Wen-Bin Ou
Journal:  Cell Cycle       Date:  2018-12-04       Impact factor: 4.534

Review 9.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

10.  Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is mediated by Grb2: an analysis of ACK1 effects on Axl signaling.

Authors:  Lin Pao-Chun; Perry M Chan; Wing Chan; Ed Manser
Journal:  J Biol Chem       Date:  2009-10-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.